Vukelja S J
Department of Medicine, Brooke Army Medical Center, Fort Sam Houston, Tex., 78234-6200.
Acta Haematol. 1994;91(4):199-200. doi: 10.1159/000204334.
Iron overload has been reported with pyruvate kinase deficiency. Erythropoietin (EPO) may lead to iron deficiency; thus, patients who are unable to be phlebotomized due to anemia may benefit from EPO as a treatment of iron overload.
据报道,丙酮酸激酶缺乏症会导致铁过载。促红细胞生成素(EPO)可能会导致缺铁;因此,因贫血而无法进行放血治疗的患者可能会受益于EPO对铁过载的治疗。